Kidswell Bio announced the completion of the exercise of stock acquisition rights with third-party allotment in July 2026, with a total exercised face value of \u00a5125 million. The monthly exercise ratio is 25%, and the remaining unexercised amount is zero.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4584","jir_company_name":"Kidswell Bio Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4584-20260722-01.pdf","jir_short_summary":"Kidswell Bio announced the completion of the exercise of stock acquisition rights with third-party allotment in July 2026, with a total exercised face value of \u00a5125 million. The monthly exercise ratio is 25%, and the remaining unexercised amount is zero.","jir_summary":"### Overview of Financial Results and Capital Policy\nKidswell Bio announced the completion of the exercise of unsecured convertible bonds with stock acquisition rights with third-party allotment in July 2026. The total exercised face value is \u00a5125 million, with an exercise ratio reaching 25%, and the unexercised remaining balance is zero. This aims to strengthen capital and improve stock liquidity.\n\n### Impact on Shareholders and Future Outlook\nWith the completion of the exercise of stock acquisition rights with third-party allotment, the dilution of shares is expected to be limited. Going forward, as part of its capital policy, the company will continue financing and shareholder return measures, and promote business expansion and growth strategies. Detailed earnings guidance and next-term plans will be announced separately.","jir_financial_highlights":"Total Exercised Face Value: 125,000 thousand yen (Exercise Completed)\nRemaining Unexercised Amount: 0 yen (Completed)\nNumber of Shares Distributed Since Beginning of Month: 946,969 shares (Newly Distributed)","jir_category":"","jir_hashtags":"#KidswellBio, #IRRelated, #JapaneseStocks","jir_key_figures":"Total Exercised Face Value: 125,000 thousand yen\nRemaining Unexercised Amount: 0 yen\nShares Distributed: 946,969 shares","jir_meta_title":"\u3010Kidswell Bio\u3011Exercise of Stock Acquisition Rights Completed \uff5c July 2026","jir_meta_description":"Kidswell Bio completed the exercise of stock acquisition rights with bonds in July 2026, achieving strengthening of capital and improvement of stock liquidity. Detailed information provided.","jir_og_title":"\u3010Kidswell Bio\u3011Exercise of Stock Acquisition Rights Completed \uff5c July 2026","jir_og_description":"Detailed explanation of Kidswell Bio\u2019s completion of the exercise of stock acquisition rights with bonds. Providing investors with the latest status of its capital policy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58797,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-86635","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n